Perceptive Advisors LLC, 10% Owner at Acrivon Therapeutics, Inc. (ACRV), sold 1,473,534 shares at $1.41 ($2.0M) on 2025-04-30, disclosed to the SEC on 2025-05-01.
Open-market sale of $2.0M ACRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.41 | 437,881 | $617K | 30.3% |
| 2 | $1.41 | 437,881 | $617K | 30.3% |
| 3 | $1.34 | 298,886 | $401K | 19.7% |
| 4 | $1.34 | 298,886 | $401K | 19.7% |
| Total | $1.38 avg | 1,473,534 | $2.0M | 100% |
| Filing → |
| ACRV | SELL | 2025-04-29 | $5.1M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |
| ATXS | BUY | 2023-12-22 | $4.6M | — | Filing → |